CancerCare's free Connect Education Workshops are a way for people to learn about cancer-related issues from the convenience of their home or office. Leading experts in oncology provide the most up-to-date information in these workshops to help you and your loved ones better understand and cope with your cancer diagnosis, treatment options, quality-of-life concerns, treatment side effects, pain management, doctor-patient communication and other important topics.
…
continue reading
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
…
continue reading
The Multiple Myeloma Research Foundation provides educational programs to help people with myeloma, family members, caregivers, and healthcare professionals learn more about the disease and today's most promising treatment options, including clinical trials, from leading multiple myeloma doctors and researchers.
…
continue reading
CureTalks features leading medical experts in conversation with a panel of patients/advocates about latest research and treatments under development.
…
continue reading
Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.
…
continue reading
Wait How Do You Spell That? is a rare disease podcast produced by Patient Worthy. We talk about issues affecting people rare and underdiagnosed conditions and interview advocates from across the community. We‘re definitely not doctors, and we can‘t give you medical advice. We‘re just here to chat and learn about the diseases that even doctors can‘t seem to spell. Check out the latest in rare disease news at PatientWorthy.com.
…
continue reading
Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews. Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.
…
continue reading
HealthTree Podcast for Multiple Myeloma brings you patient-led interviews of the world's top multiple myeloma researchers. Call in live at showtime to (347) 637-2631 ask questions and to learn about the latest innovation in simple terms patients can understand.
…
continue reading
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healt ...
…
continue reading
Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.
…
continue reading
Sit back and listen to Ulf-Henrik Mellqvist talking about the significant developments in the field of multiple myeloma treatment. What do the new possibilities mean for patients and doctors? And why should young doctors looking to specialize go into hematology?
…
continue reading
Welcome to the Clinical Care Solutions Oncology podcast channel. Our podcast shows give you quick access to important content when you need it - at home, at your desk, or on the go.
…
continue reading
The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.
…
continue reading
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest ...
…
continue reading
The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.
…
continue reading
Welcome to the mibo show, where we focus on mind and body wellness… let’s talk about it!!! Each episode our guests will talk about their mental and/or physical health journey or that of their family. We will also have subject matter experts talk health facts and stats, best practices for wellness, and provide strategies to encourage us all how to live a healthy lifestyle where we prioritize our mind and body wellness on a regular basis!
…
continue reading
The Cancer Revolution podcast series looks to explore all areas of integrative, traditional and alternative means of beating cancer and creating sustained good health, for the young folks and old. Our topics will include areas such as immune system, metabolic theory, epigenetic, microbial connections, diet, mitigating side effects of cancer treatments, detoxification methods, anticancer nutrition, the latest news and stories in institutional cancer research
…
continue reading
Audio-reports and interviews done in collaboration with Audio Medica and its founding Editor Peter Goodwin. Audio Medica's Audio Journal of Oncology has been bringing lively listen-in shows to members of the cancer care team in various audio formats since 1992. Scientific Editors are George Canellos, MD, of Dana-Farber Cancer Institute; J. Gordon McVie, MD, of the European Institute of Oncology and Chair of the Editorial Board of OT's UK Edition; Pat Price, MD, of Christie Hospital, also on ...
…
continue reading
The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcare professionals involved in the management and care of cancer patients as well as cancer patients and their family and friends. If you like to join us as a sponsor or advertisers, download our med ...
…
continue reading
As the leading authoritative, peer-reviewed audio source of oncology clinical news for clinicians and healthcare professionals, the AJO Podcast regularly brings you exclusive interviews with the world's leading researchers and clinicians responsible for pushing out the boundaries of science and practice. Medicine, screening, radiotherapy, surgery, clinical trials, cancer care, epidemiology and prevention are covered impartially to give busy cancer professionals access to conversational spoke ...
…
continue reading
1
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series
58:58
58:58
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
58:58
Dr Matthew S Davids from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews current available data and ongoing investigational treatment approaches for chronic lymphocytic leukemia.Kirjoittanut Neil Love, MD
…
continue reading
1
Using NGS to refine risk stratification in T-ALL; a novel gene therapy approach in severe α-thalassemia; molecular taxonomy of MDS
21:48
21:48
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
21:48
In this week's episode we'll learn about refining risk stratification in T-cell acute lymphoblastic leukemia, or ALL. After that, we'll discuss a novel gene therapy approach in severe alpha-thalassemia. Investigators describe an innovative mouse model and an effective gene therapy approach, renewing prospects for the development of novel strategies…
…
continue reading
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Ryan Cassaday, MD From a relatively poor prognosis to severe toxicity risks, patients with relapsed/refractory acute lymphoblastic leukemia (ALL) and the clinicians caring for them face several treatment challenges. Joining Dr. Charles Turck to discuss those unmet needs—and perhaps even more important…
…
continue reading
1
Yvette Nicole Brown - Caretaking During Alzheimer's
54:13
54:13
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
54:13
In this episode of the mibo show, Shanti Das speaks with actress, host and caretaker Yvette Nicole Brown about her journey as an Alzheimer’s caretaker and advocate. Brown discusses her years of taking care of her father and the ups and downs that come with caring for a loved one. Shanti also opens up about her own personal experience as a caretaker…
…
continue reading
1
Targeting BCMA in multiple myeloma: Insights from COMy and EHA 2024
57:31
57:31
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
57:31
touchCONGRESS for touchONCOLOGY Listen to multiple myeloma expert Prof. María-Victoria Mateos review key data for BCMA-targeting agents in the treatment of multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy) and European Hematology Association (EHA) 2024 congresses. Prof. Mateos is then joined by fellow experts …
…
continue reading
1
Innovations in glaucoma care: Targeting pathophysiology to expand treatment options
33:45
33:45
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
33:45
touchEXPERT OPINIONS for touchOPHTHALMOLOGY Listen to leading experts describe the pathophysiology of open-angle glaucoma and discuss how it is targeted by current and emerging treatment options, while providing insights on how different agents and combinations are used in practice. The experts Angelo P Tanna, MD - Northwestern University Feinberg …
…
continue reading
Dr. Deborah Wong, Director of the Medical Oncology Program and Clinical Trials Program for Head and Neck Squamous Cell Cancers (HNSCC) and an Associate Clinical Professor of Medicine at the University of California Los Angeles (UCLA) is currently serving as co-chair of i3 Health’s accredited CME/NCPD activity, Recurrent and Metastatic HNSCC, Harnes…
…
continue reading
1
All About Koolen de-Vries Syndrome, feat. Patient Advocate Ashley Point
26:49
26:49
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
26:49
In this episode of the podcast we speak to Ashley Point, a patient advocate advocate whose son Davis was diagnosed with Koolen de-Vries Syndrome (KdVS) in 2016. She also serves as the president for both the Koolen de-Vries Syndrome Foundation and My Kool Brother, two non-profits that help to support families living with KdVS through advocacy, resea…
…
continue reading
1
A novel tripartite fusion drives treatment resistance in atypical APL; managing iTTP without TPE; hope for motherhood after allogeneic HCT
18:30
18:30
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
18:30
In this week's episode we’ll discuss a novel tripartite fusion drives treatment resistance in acute promyelocytic leukemia. In some patients with atypical APL, these novel retinoic acid receptor gene fusions result in truncation of the ligand binding domain of the retinoic acid receptor protein, resulting in non-responsiveness to treatment with all…
…
continue reading
1
Understanding Treatment Decisions and Management for Patients with Advanced Renal Cell Carcinoma Using Hypothetical Case Studies: A Vodcast
46:25
46:25
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
46:25
In this episode, two experts in the field of kidney cancer, Dr Benjamin Garmezy and Dr Vaishampayan, will present hypothetical case studies that represent typical patients seen with advanced renal cell carcinoma (aRCC) in practice. The faculty will discuss treatment approaches, adverse event management, and which factors to consider during the trea…
…
continue reading
Host: Matt Birnholz, MD The SIMPLIFY-2 trial compared the efficacy of momelotinib to best available therapy, which was primarily continued ruxolitinib, in patients with myelofibrosis and anemia who were previously treated with a JAK inhibitor. According to the findings, momelotinib potentially offers better outcomes and a more comprehensive managem…
…
continue reading
1
ESMO 2024 Congress Highlights in Gynecologic Cancer: New Data Informing Treatment of Ovarian, Endometrial, and Cervical Cancers
30:45
30:45
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
30:45
In this episode, listen to Ana Oaknin, MD, PhD and Alexandra Leary, MD, PhD, share their clinical insights and takeaways on key updates and new data presented for ovarian, endometrial, and cervical cancer at the ESMO 2024 annual congress including: Phase III PRIMA/ENGOT-OV26/GOG-3012 Final OS Results: Niraparib as First-Line Maintenance in Advanced…
…
continue reading
1
Amplify and Act: Case-Based Discussions With Heart Failure Experts
47:22
47:22
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
47:22
Learn more about the latest guidelines and the importance of patient centricity when treating your patients with heart failure. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001661?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Experts in dermatology discuss the latest in treating moderate-to-severe atopic dermatitis in children and adolescents
40:07
40:07
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
40:07
touchIN CONVERSATION for touchIMMUNOLOGY Listen to Prof. Diamant Thaçi in conversation with Dr Benjamin Ungar. They respond to questions submitted by the HCP audience and provide their expert insights regarding managing moderate–severe atopic dermatitis (AD) in children and adolescents, including assessing the severity of AD, selecting systemic the…
…
continue reading
1
A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance
32:48
32:48
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
32:48
In this episode, listen to Matthew S. Davids, MD, MMSc, and Lindsey Roeker, MD, discuss BTK inhibitor resistance and how it shapes treatment choices for patients with CLL, including: Contemporary treatment paradigms for patients with CLL Safety and efficacy of current regimens Molecular testing, including when and how to test for BTK inhibitor res…
…
continue reading
1
Pirtobrutinib plus venetoclax with or without rituximab in relapsed/refractory CLL; murine models of erythroid 5ALA synthesis disorders; targeting PKCa in diabetes and hemochromatosis
23:17
23:17
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
23:17
In this week's episode we’ll discuss the safety and efficacy of pirtobrutinib with or without rituximab in relapsed/refractory CLL; learn more about erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine; and discuss how targeting PKC alpha alleviates iron overload in diabetes and hemochromatosis through …
…
continue reading
1
Updates in recurrent/metastatic nasopharyngeal carcinoma: The evolving role of immune checkpoint inhibitors
18:41
18:41
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
18:41
touchFOCUS for touchONCOLOGY Listen to Prof. Barbara Burtness as she answers a series of questions focused on the evolving role of immune checkpoint inhibitors in the first- and subsequent-line settings for recurrent/metastatic nasopharyngeal carcinoma. The expert Prof. Barbara Burtness, Yale School of Medicine, New Haven, CT, USA This touchPODCAST…
…
continue reading
1
touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchDERMATOLOGY
15:04
15:04
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
15:04
touchMDT for touchDERMATOLOGY Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling. The mult…
…
continue reading
1
touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchDERMATOLOGY
12:49
12:49
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
12:49
touchMDT for touchDERMATOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC). The multidisciplinary team and patient advocate: Hepatologist – …
…
continue reading
1
touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchENDOCRINOLOGY
14:47
14:47
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
14:47
touchMDT for touchENDOCRINOLOGY Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice. The multidisciplinary team: Nurse – Ms Michelle Clayton St James’ Univ…
…
continue reading
1
touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchENDOCRINOLOGY
12:49
12:49
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
12:49
touchMDT for touchENDOCRINOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC). The multidisciplinary team and patient advocate: Hepatologist …
…
continue reading
1
touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchENDOCRINOLOGY
15:05
15:05
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
15:05
touchMDT for touchENDOCRINOLOGY Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling. The mu…
…
continue reading
1
touchMDT – A comprehensive approach to symptom care in PBC – Discussion 3 - touchIMMUNOLOGY
15:05
15:05
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
15:05
touchMDT for touchIMMUNOLOGY Listen to experts Prof. Sonja Ständer, Ms Michelle Clayton, Prof. Gideon Hirschfield and patient advocate, Mrs Collette Thain MBE, discuss individualizing management strategies for patients with cholestatic pruritus and primary biliary cholangitis (PBC), and the importance of patient education and counselling. The multi…
…
continue reading
1
touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchDERMATOLOGY
14:46
14:46
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
14:46
touchMDT for touchDERMATOLOGY Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice. The multidisciplinary team: Nurse – Ms Michelle Clayton St James’ Univer…
…
continue reading
1
touchMDT – Symptom assessment and monitoring in clinical practice – Discussion 2 - touchIMMUNOLOGY
14:47
14:47
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
14:47
touchMDT for touchIMMUNOLOGY Listen to experts Ms Michelle Clayton, Prof. Sonja Ständer and Prof. Gideon Hirschfield discuss the importance of assessing for cholestatic pruritus in patients with primary biliary cholangitis (PBC) and review the tools used in clinical practice. The multidisciplinary team: Nurse – Ms Michelle Clayton St James’ Univers…
…
continue reading
1
touchMDT – Pruritus in PBC and me: The patient experience – Discussion 1 - touchIMMUNOLOGY
12:49
12:49
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
12:49
touchMDT for touchIMMUNOLOGY Pruritus in PBC and me: The patient experience Listen to experts Prof. Gideon Hirschfield and Prof. Sonja Ständer, plus patient advocate Mrs Collette Thain MBE, explore the burden of cholestatic pruritus in patients with primary biliary cholangitis (PBC). The multidisciplinary team and patient advocate: Hepatologist – P…
…
continue reading
1
Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease. Module 1: EGFR-mutant NSCLC:
33:56
33:56
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
33:56
touchCLINICAL PERSPECTIVES for touchRESPIRATORY Listen to Dr Helena Yu outline the unmet needs and areas for research in metastatic EGFR-mutant NSCLC. Dr Antonio Passaro goes on to review the key clinical trial data in the first- and second-line settings, followed by a discussion of a patient case by Dr Helena Yu to highlight how novel agents and t…
…
continue reading
1
Perspectives on EGFR-mutant and wildtype NSCLC: Tailoring treatment advances in late-stage disease Module 1: EGFR-mutant NSCLC:
33:56
33:56
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
33:56
touchCLINICAL PERSPECTIVES for touchONCOLOGY Listen to Dr Helena Yu outline the unmet needs and areas for research in metastatic EGFR-mutant NSCLC. Dr Antonio Passaro goes on to review the key clinical trial data in the first- and second-line settings, followed by a discussion of a patient case by Dr Helena Yu to highlight how novel agents and trea…
…
continue reading
1
Navigating Patients Through the CKD Journey with Value-Based Care Plus CPE-Accredited Podcast
1:55:41
1:55:41
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
1:55:41
Jeff Sperry, PharmD, BCPS, a Clinical Pharmacist at UCHealth Memorial Hospital, discusses additional advances in chronic kidney disease since recording the i3Health CPE-accredited activity, Slowing Progression of Chronic Kidney Disease Through Value-Based Care. Following the interview, continue listening for the complete CPE-accredited podcast.Clic…
…
continue reading
1
Lowering the Cardiovascular Burden With Novel Weight Loss Therapies: An Expert Digest From ESC
20:26
20:26
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
20:26
What do ESC 2024 data mean for reducing cardiovascular risk in clinical practice with incretin-based agents? Credit available for this activity expires: 9/24/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001648?ecd=bdc_podcast_libsyn_mscpedu
…
continue reading
1
Expanding HER2 horizons: Implications for NSCLC and beyond
41:45
41:45
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
41:45
touchPANEL DISCUSSION for touchRESPIRATORY Listen to three experts as they explore tissue-agnostic HER2 targeting in solid tumours, the latest clinical trial data for approved and emerging HER2-targeted therapies in NSCLC, and best practices for testing for HER2 alterations in NSCLC. The experts Dr Razelle Kurzrock - Medical Oncologist, Medical Col…
…
continue reading
1
Transplant outcomes in pediatric Fanconi anemia; hepatic Foxo1 regulates iron homeostasis; clinical networks improve APL outcomes in Latin America
18:42
18:42
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
18:42
In this week's episode we'll discuss outcomes following hematopoietic stem cell transplantation in pediatric patients with Fanconi anemia. Then, we'll learn about how new research shows that the transcription factor Foxo1, commonly associated with glucose metabolism, regulates hepcidin expression and systemic iron homeostasis. Finally, in Latin Ame…
…
continue reading
Guest: Betsy O'Donnell, MD Plasma cell disorders range from multiple myeloma to the monoclonal gammopathy of undetermined significance (MGUS), which is a benign condition that affects anywhere between 3 and 10 percent of the population starting at age 50. However, about 1 percent of people per year who have MGUS will progress to multiple myeloma. H…
…
continue reading
1
CD8+ T-cell differentiation and treatment response in AML; ATM germline pathogenic variants affect cancer outcomes in ataxia-telangiectasia; efficacy of a selective menin-KMT2A inhibitor in KMT2A- and ...
22:42
22:42
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
22:42
In this week's episode we’ll discuss how CD8+ T-cell differentiation and dysfunction inform treatment response in acute myeloid leukemia; learn more about the effect of ATM germline pathogenic variants on the outcomes in children with ataxia-telangiectasia and hematological malignancies; and discuss the preclinical efficacy of a potent, selective m…
…
continue reading
1
Current Perspectives on Cancer Survivorship
55:47
55:47
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
55:47
- Overview of Cancer Survivorship- Managing Post Treatment Side Effects/Late Effects- Quality-of-Life Concerns- Fear of Recurrence- Finding Your New Normal- The Importance of Treatment Summaries and Encounter Notes- Follow-Up with Your Oncologist and Primary Care Doctor, Including Discussion of Health Screening and Concerns- Guidelines to Prepare f…
…
continue reading
1
Mitigating Disease Burden and Health Care Disparities in Relapsed/Refractory Multiple Myeloma
33:18
33:18
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
33:18
Listen now to this CME-accredited podcast, part of the Multiple Myeloma Task Force series, where we will explore strategies for mitigating disease burden and addressing health care disparities in patients with relapsed/refractory multiple myeloma. This session brings together expert insights from Task Force Co-Chairs, Dr. Sikander Ailawadhi, Profes…
…
continue reading
1
The Rise of the Machines: A Quickfire Exploration of Artificial Intelligence and Big Data in Oncology
17:51
17:51
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
17:51
Did you know that artificial intelligence (AI) is shaping the future of oncology? Our expert faculty discuss in this rapid question and answer program! Credit available for this activity expires: 9/6/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001549?ecd=bdc_podcast_libsyn_mscpedu…
…
continue reading
Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Joshua E. Reuss, MD The phase 2 ICARUS-Lung01 study evaluated not only the efficacy and safety of datopotomab deruxtecan (Dato-DXd) in patients with previously treated advanced non-small cell lung cancer (NSCLC), but also potential biomarkers associated with response and/or resistance. Here to discuss…
…
continue reading
1
Additional Advances in Immune-Related Adverse Events Research and Trials: Beth Sandy, MSN, CRNP
12:21
12:21
Toista myöhemmin
Toista myöhemmin
Listat
Tykkää
Tykätty
12:21
Click here to view the full activity and claim free NCPD credit! https://i3health.com/course-information/managing-immune-related-adverse-events-to-ensure-optimal-cancer-immunotherapy-outcomes-the-nurses-viewAt last year’s Greater Los Angeles Oncology Nursing Society (GLAONS) Oncology Care Summit, i3 Health hosted a nursing continuing professional d…
…
continue reading